Elliott A C, Bruce J I
Cell Physiology Group, School of Biological Sciences (G 38), University of Manchester, UK.
Digestion. 1997;58 Suppl 2:69-74. doi: 10.1159/000201547.
Since they were first reported in hepatocytes in 1986, agonist-evoked oscillations in intracellular free calcium ([Ca2+]i) have been described in numerous cell types, including pancreatic exocrine and endocrine cells. Pancreatic acinar cells show both 'sinusoidal' [Ca2+]i oscillations (when stimulated with muscarinic agonists) and so-called 'baseline [Ca2+]i spiking' (when stimulated with cholecystokinin, bombesin or analogues of either peptide). These agonist-evoked [Ca2+]i oscillations present novel problems to the investigator, particularly since they show considerable cell-to-cell variability. In this review, we discuss the various approaches available for analysing [Ca2+]i oscillations, particularly with respect to assessing whether drugs or other experimental interventions alter the oscillation pattern.
自1986年首次在肝细胞中被报道以来,激动剂诱发的细胞内游离钙([Ca2+]i)振荡已在包括胰腺外分泌和内分泌细胞在内的多种细胞类型中被描述。胰腺腺泡细胞既表现出“正弦波式”的[Ca2+]i振荡(用毒蕈碱激动剂刺激时),也表现出所谓的“基线[Ca2+]i尖峰”(用胆囊收缩素、蛙皮素或任一肽的类似物刺激时)。这些激动剂诱发的[Ca2+]i振荡给研究者带来了新问题,尤其是因为它们在细胞间表现出相当大的变异性。在这篇综述中,我们讨论了可用于分析[Ca2+]i振荡的各种方法,特别是在评估药物或其他实验干预是否改变振荡模式方面。